Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Duolingo, Inc.DUOL · Entity 3679 | Director | October 10, 2026 | October 14, 2026 |
| Khosla Ventures Acquisition Co.KVSA · Entity 141683 | Director | March 03, 2021 | March 03, 2021 |
| Oscar Health, Inc.OSCR · Entity 3582 | Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Duolingo, Inc.
Report date October 10, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 4,378 |
Reported balance
After 2026-10-10 transaction · row 1
1 source rowRow 1 · 2026-10-10 · Grant · Acquired 116 · Balance 4,378 F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan.
Khosla Ventures Acquisition Co.
Report date March 03, 2021 · Filed March 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-03-03 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer.
Oscar Health, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 449,444 |
Reported balance
After 2026-09-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 31,422 · Balance 449,444 F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2026 Filed Oct 14, 2026 00:13 UTC | Duolingo, Inc. DUOL · Entity 3679 | GrantClass A Common Stock | 116 | $149.92 | $17,390.72 |
DisclosureSEC source: 0001628280-26-065789 · wk-form4_1791936793.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,378 F1 · shares: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 31,422 | $31.45 | $988,221.90 |
DisclosureSEC source: 0001844320-26-000018 · wk-form4_1788898567.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 449,444 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| August 28, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 10 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,212,293 Underlying: Class A Common Stock · 150,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| August 28, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 150,000 | $9.75 | $1,462,500.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 9 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,362,293 Underlying: Class A Common Stock · 150,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| August 28, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $9.75 | $0.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 8 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,990,000 Underlying: Class B Common Stock · 150,000 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 16, 2029. Read SEC document |
| August 28, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 150,000 | $30.79 | $4,618,500.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,866 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| August 28, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 7 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,212,293 Underlying: Class A Common Stock · 600,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 600,000 | $9.75 | $5,850,000.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 6 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,812,293 Underlying: Class A Common Stock · 600,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $9.75 | $0.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · derivative · entry 5 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,140,000 Underlying: Class B Common Stock · 600,000 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 16, 2029. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 600,000 | $30.34 | $18,204,000.00 |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,866 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 600,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000016 · wk-form4_1788207372.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,080,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 22:39 UTC | Duolingo, Inc. DUOL · Entity 3679 | GrantClass A Common Stock | 140 | $124.76 | $17,466.40 |
DisclosureSEC source: 0001628280-26-048221 · wk-form4_1784068753.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,262 F1 · shares: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000013 · wk-form4_1783368657.xml · derivative · entry 6 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 538,333 Underlying: Class A Common Stock · 47,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F3 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 30,228 | $31.65 | $956,716.20 |
DisclosureSEC source: 0001844320-26-000013 · wk-form4_1783368657.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 0 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 13,672 | $30.80 | $421,097.60 |
DisclosureSEC source: 0001844320-26-000013 · wk-form4_1783368657.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 30,228 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 3,600 | $29.50 | $106,200.00 |
DisclosureSEC source: 0001844320-26-000013 · wk-form4_1783368657.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 43,900 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000013 · wk-form4_1783368657.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 47,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F3 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 22 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 585,833 Underlying: Class A Common Stock · 47,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 21 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Siena Pizzo-Schlosser Dynasty Trust Disclosed balance after: 283,333 Underlying: Class A Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 20 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Noah Pizzo-Schlosser Dynasty Trust Disclosed balance after: 283,333 Underlying: Class A Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 880,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 19 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,212,293 Underlying: Class A Common Stock · 880,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass B Common Stock · Derivative | 660,000 | $9.75 | $6,435,000.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 18 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,092,293 Underlying: Class A Common Stock · 660,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionStock Option (Right to Buy) · Derivative | 660,000 | $0.00 Strike: $9.75 | $0.00 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · derivative · entry 17 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,740,000 Underlying: Class B Common Stock · 660,000 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F7 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 16, 2029. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 97 | $30.09 | $2,918.73 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 16 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 0 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 31,912 | $29.58 | $943,956.96 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 15 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 97 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.08 to $30.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 15,491 | $28.95 | $448,464.45 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 14 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 32,009 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 13 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Pizzo-Schlosser Family Dynasty Trust Disclosed balance after: 47,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 102 | $30.09 | $3,069.18 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 12 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Siena Pizzo-Schlosser Dynasty Trust Disclosed balance after: 0 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 33,592 | $29.58 | $993,651.36 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 11 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Siena Pizzo-Schlosser Dynasty Trust Disclosed balance after: 102 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.08 to $30.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 16,306 | $28.95 | $472,058.70 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 10 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Siena Pizzo-Schlosser Dynasty Trust Disclosed balance after: 33,694 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 9 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Siena Pizzo-Schlosser Dynasty Trust Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 102 | $30.09 | $3,069.18 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 8 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Noah Pizzo-Schlosser Dynasty Trust Disclosed balance after: 0 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 33,591 | $29.58 | $993,621.78 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 7 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Noah Pizzo-Schlosser Dynasty Trust Disclosed balance after: 102 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.08 to $30.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 16,307 | $28.95 | $472,087.65 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 6 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Noah Pizzo-Schlosser Dynasty Trust Disclosed balance after: 33,693 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 5 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Noah Pizzo-Schlosser Dynasty Trust Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F6 · ownership.nature: Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 1,799 | $30.09 | $54,131.91 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 4 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,866 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 591,213 | $29.58 | $17,488,080.54 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 3 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 482,665 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.08 to $30.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 286,988 | $28.95 | $8,308,302.60 |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,073,878 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 880,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000011 · wk-form4_1782418619.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,360,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:24 UTC | Duolingo, Inc. DUOL · Entity 3679 | GrantClass A Common Stock | 2,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041251 · wk-form4_1780691096.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,122 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Issuer's Class A Common Stock for each RSU upon vesting. 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 9,668 | $22.45 | $217,046.60 |
DisclosureSEC source: 0001844320-26-000009 · wk-form4_1780604207.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,866 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 24,452 | $21.74 | $531,586.48 |
DisclosureSEC source: 0001844320-26-000009 · wk-form4_1780604207.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 490,534 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 24,335 | $13.39 | $325,845.65 |
DisclosureSEC source: 0001568651-26-000022 · wk-form4_1772659072.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 514,986 F3 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 189,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001568651-26-000022 · wk-form4_1772659072.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 539,321 F1 · shares: The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 23,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000006 · primarydocument.xml · derivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,432,293 Underlying: Class A Common Stock · 23,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 23,038 | $17.65 | $406,620.70 |
DisclosureSEC source: 0001844320-26-000006 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,180 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 21:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass A Common Stock | 23,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001844320-26-000006 · primarydocument.xml · nonDerivative · entry 1 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 373,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | ConversionClass B Common Stock · Derivative | 76,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001844320-26-000004 · primarydocument.xml · derivative · entry 3 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,455,331 Underlying: Class A Common Stock · 76,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 76,962 | $17.01 | $1,309,123.62 |
DisclosureSEC source: 0001844320-26-000004 · primarydocument.xml · nonDerivative · entry 2 Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,180 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.